カテゴリー： 世界, 医療/バイオ, visiongain

世界の心血管装置市場2023年～2033年

【英語タイトル】Cardiovascular Devices Market Report 2023-2033 : Forecasts by Disease (Hypertension, Atrial Fibrillation, Chronic Ischemic Heart Diseases, Stroke, Heart Failure, Other), by Type (Diagnostic and Monitoring Devices, Therapeutic, Surgical Devices), by End-users (Hospitals, Diagnostic Laboratories, Home and Ambulatory Care, Research Laboratories) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

visiongainが出版した調査資料（VGA23FB012）・商品コード：VGA23FB012
・発行会社（調査会社）：visiongain
・発行日：2022年12月14日
・ページ数：273
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Sigle User（1名様閲覧用、1年間、印刷不可）GBP3,950 ⇒換算￥750,500見積依頼/購入/質問フォーム
Enterprise（法人閲覧用、1年間、印刷可）GBP6,950 ⇒換算￥1,320,500見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Visiongain社の本調査レポートでは、世界の心血管装置市場規模が2033年までに年平均6.92%で成長すると予測しています。本レポートは、心血管装置の世界市場を徹底調査し、レポート概要、エグゼクティブサマリー、市場動向、疾患別（高血圧症、心房細動、慢性虚血性心疾患、ストローク、その他）分析、種類別（診断＆監視装置、治療＆手術用装置）分析、エンドユーザー別（病院、診断ラボ、在宅＆外来診療、研究所）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、企業情報などの内容を作成しました。本書には、Abbott、B. Braun SE、BD、BIOTRONIK SE & CO. KG、Boston Scientific Corporation、Canon Medical Systems Corporation、Cardinal Health、Cook Group、Edwards Lifesciences Corporation、GE Healthcare、Johnson & Johnson Services, Inc.、Koninklijke Philips N.V.などの企業情報が含まれています。
・レポート概要
・エグゼクティブサマリー
・市場動向
・世界の心血管装置市場規模：疾患別
- 高血圧症における市場規模
- 心房細動における市場規模
- 慢性虚血性心疾患における市場規模
- ストロークにおける市場規模
- その他疾患における市場規模
・世界の心血管装置市場規模：種類別
- 診断＆監視装置の市場規模
- 治療＆手術用装置の市場規模
・世界の心血管装置市場規模：エンドユーザー別
- 病院における市場規模
- 診断ラボにおける市場規模
- 在宅＆外来診療における市場規模
- 研究所における市場規模
・世界の心血管装置市場規模：地域別
- 北米の心血管装置市場規模
- ヨーロッパの心血管装置市場規模
- アジア太平洋の心血管装置市場規模
- 中南米の心血管装置市場規模
- 中東・アフリカの心血管装置市場規模
・企業情報

The Cardiovascular Devices Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growth Potential in Emerging Economies
The high occurrence of diabetes along with the large geriatric population in these emerging economies such as Japan, India, China, & Brazil provides substantial development opportunities for the cardiovascular devices market. As per the World Health Organization over 18 million people die due to CVDs each year. Of these deaths, over three-fourths deaths are attributed to heart attack and stroke. Besides, approximately two-thirds of CVD deaths take place in low-and middle-income nations where high blood pressure (BP) is amongst the most important risk factors. People at risk of CVD may exhibit high BP, glucose, and lipid along with overweight and obesity. To identify those at the maximum risk of CVDs along with to ensure they receive suitable treatment is expected to prevent premature deaths. In Brazil, non-communicable diseases (NCDs), accounted for approximately three-fourths of total deaths. Therefore, potential across emerging nations is projected to provide lucrative growth opportunities for the regional market players.

Growing Availability of Efficient Devices
The cardiovascular devices market is expected to witness exponential growth in the future with the high adoption of cutting-edge technologies to serve the rising disease burden. In addition, there has been an increase in the incidence of heart diseases globally, which leads to the demand for efficient and state-of-the-art heart devices. The availability of cutting-edge devices has led to the implementation of these devices in developed nations. Besides, there has been a rise in government initiatives along with funding for research and development activities. Further, investors are focusing on escalating the availability of advanced and economical cardiovascular devices in emerging markets. For instance, in 2020, AliveCor, one of the leading enterprise cardiac solution and AI-based ECG technology providers, launched KardiaMobile device in Mexico. This device is used to store, record, and transfer single-channel electrocardiogram rhythms from the patients. This launch was done through a partnership between AliveCor and Mexico-based Inpharamo, a medical solutions company. Hence, growth in accessibility of efficient devices is projected to offer lucrative growth prospects over the forecast period.

What Questions Should You Ask before Buying a Market Research Report?
• How is the cardiovascular devices market evolving?
• What is driving and restraining the cardiovascular devices market?
• How will each cardiovascular devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each cardiovascular devices submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading cardiovascular devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the cardiovascular devices projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
cardiovascular devices projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the cardiovascular devices market?
• Where is the cardiovascular devices market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the cardiovascular devices market today, and over the next 10 years:
• Our 273-page report provides 112 tables and 170 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the cardiovascular devices market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Disease
• Hypertension
• Atrial Fibrillation
• Chronic Ischemic Heart Diseases
• Stroke
• Heart Failure
• Other Diseases

Type
• Diagnostic and Monitoring Devices
• Therapeutic and Surgical Devices

End-users
• Hospitals
• Diagnostic Laboratories
• Home and Ambulatory Care
• Research Laboratories

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Cardiovascular Devices Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott
• B. Braun SE
• BD
• BIOTRONIK SE & CO. KG
• Boston Scientific Corporation
• Canon Medical Systems Corporation
• Cardinal Health
• Cook Group
• Edwards Lifesciences Corporation
• GE Healthcare
• Johnson & Johnson Services, Inc.
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic plc
• Siemens Healthcare GmbH
• Terumo Corporation
• W. L. Gore & Associates, Inc.

Overall world revenue for Cardiovascular Devices Market, 2023 to 2033 in terms of value the market will surpass US$65 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Cardiovascular Devices Market, 2023 to 2033 report help you?
In summary, our 270+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Cardiovascular Devices Market, 2023 to 2033 Market, with forecasts for Disease, Type, and End-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 21 key national markets – See forecasts for the Cardiovascular Devices Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 17 of the major companies involved in the Cardiovascular Devices Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Cardiovascular Devices Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Cardiovascular Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Prevalence of Obesity
3.2.1.2 Rising Consumption of Tobacco
3.2.1.3 Increasing Incidence of Coronary Artery Diseases (CAD)
3.2.2 Market Restraining Factors
3.2.2.1 Stringent Regulatory Requirements Delaying the Approval of Cardiac Devices
3.2.3 Market Opportunities
3.2.3.1 Growth Potential in Emerging Economies
3.2.3.2 Growing Availability of Efficient Devices
3.3 Porter’s Five Forces Analysis
3.3.1 Supplier Power
3.3.2 Buyer Power
3.3.3 Competitive Rivalry
3.3.4 Threat from Substitutes
3.3.5 Threat of New Entrants
3.4 PESTLE Analysis
3.5 COVID-19 Impact Analysis

4 Cardiovascular Devices Market Analysis by Disease
4.1 Key Findings
4.2 Disease Segment: Market Attractiveness Index
4.3 Cardiovascular Devices Market Size Estimation and Forecast by Disease
4.4 Hypertension
4.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Atrial Fibrillation
4.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Chronic Ischemic Heart Diseases
4.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Stroke
4.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Heart Failure
4.8.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Other Diseases
4.9.1 Market Forecast by Region, 2023-2033 (US$ bn)
4.9.2 Market Share by Region, 2023 & 2033 (%)

5 Cardiovascular Devices Market Analysis by Type
5.1 Key Findings
5.2 Type Segment: Market Attractiveness Index
5.3 Cardiovascular Devices Market Size Estimation and Forecast by Type
5.4 Diagnostic and Monitoring Devices
5.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Therapeutic and Surgical Devices
5.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
5.5.2 Market Share by Region, 2023 & 2033 (%)

6 Cardiovascular Devices Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Cardiovascular Devices Market Size Estimation and Forecast by End-users
6.4 Hospitals
6.4.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Diagnostic Laboratories
6.5.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Home and Ambulatory Care
6.6.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Research Laboratories
6.7.1 Market Forecast by Region, 2023-2033 (US$ bn)
6.7.2 Market Share by Region, 2023 & 2033 (%)

7 Cardiovascular Devices Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast

8 North America Cardiovascular Devices Market Analysis
8.1 Key Findings
8.2 North America Cardiovascular Devices Market Attractiveness Index
8.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
8.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
8.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
8.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
8.8 U.S. Cardiovascular Devices Market Analysis
8.9 Canada Cardiovascular Devices Market Analysis

9 Europe Cardiovascular Devices Market Analysis
9.1 Key Findings
9.2 Europe Cardiovascular Devices Market Attractiveness Index
9.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
9.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
9.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
9.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
9.8 Germany Cardiovascular Devices Market Analysis
9.9 UK Cardiovascular Devices Market Analysis
9.10 France Cardiovascular Devices Market Analysis
9.11 Italy Cardiovascular Devices Market Analysis
9.12 Spain Cardiovascular Devices Market Analysis
9.13 Russia Cardiovascular Devices Market Analysis
9.14 Rest of Europe Cardiovascular Devices Market Analysis

10 Asia Pacific Cardiovascular Devices Market Analysis
10.1 Key Findings
10.2 Asia Pacific Cardiovascular Devices Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
10.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
10.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
10.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
10.8 Japan Cardiovascular Devices Market Analysis
10.9 China Cardiovascular Devices Market Analysis
10.10 India Cardiovascular Devices Market Analysis
10.11 Australia Cardiovascular Devices Market Analysis
10.12 South Korea Cardiovascular Devices Market Analysis
10.13 Rest of Asia Pacific Cardiovascular Devices Market Analysis

11 Latin America Cardiovascular Devices Market Analysis
11.1 Key Findings
11.2 Latin America Cardiovascular Devices Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
11.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
11.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
11.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
11.8 Brazil Cardiovascular Devices Market Analysis
11.9 Mexico Cardiovascular Devices Market Analysis
11.10 Rest of Latin America Cardiovascular Devices Market Analysis

12 MEA Cardiovascular Devices Market Analysis
12.1 Key Findings
12.2 MEA Cardiovascular Devices Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ bn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ bn)
12.5 Market Size Estimation and Forecast by Disease, 2023-2033 (US$ bn)
12.6 Market Size Estimation and Forecast by Type, 2023-2033 (US$ bn)
12.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ bn)
12.8 GCC Cardiovascular Devices Market Analysis
12.9 South Africa Cardiovascular Devices Market Analysis
12.10 Rest of MEA Cardiovascular Devices Market Analysis

13 Company Profiles
13.1 Abbott
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2017-2021
13.1.3.2 Regional Market Shares, 2021
13.1.3.3 Gross Profit, 2017-2021
13.1.3.4 R&D, 2017-2021
13.1.4 Product Benchmarking
13.1.5 Strategic Outlook
13.2 B. Braun SE
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2017-2021
13.2.3.2 Regional Market Shares, 2021
13.2.3.3 Gross Profit, 2017-2021
13.2.3.4 R&D, 2017-2021
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 Boston Scientific Corporation
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 Regional Market Shares, 2021
13.3.3.3 Gross Profit, 2017-2021
13.3.3.4 R&D, 2017-2021
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Becton, Dickinson and Company (BD)
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 Regional Market Shares, 2021
13.4.3.3 Gross Profit, 2017-2021
13.4.3.4 R&D, 2017-2021
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Cardinal Health
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2021
13.5.3.2 Regional Market Shares, 2021
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 Cook Group
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.6.4 Strategic Outlook
13.7 Medtronic
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 Regional Market Shares, 2021
13.7.3.3 R&D, 2017-2021
13.7.4 Product Benchmarking
13.7.5 Strategic Outlook
13.8 Terumo Corporation
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2017-2021
13.8.3.2 Regional Market Shares, 2022
13.8.3.3 Gross Profit, 2017-2021
13.8.4 Product Benchmarking
13.8.5 Strategic Outlook
13.9 Koninklijke Philips N.V.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 Regional Market Shares, 2021
13.9.3.3 Gross Profit, 2017-2021
13.9.3.4 R&D, 2017-2021
13.9.4 Product Benchmarking
13.9.5 Strategic Outlook
13.10 BIOTRONIK SE & CO. KG
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
13.10.4 Strategic Outlook
13.11 W. L. Gore & Associates, Inc.
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Strategic Outlook
13.12 GE Healthcare
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2017-2021
13.12.3.2 Regional Market Shares, 2021
13.12.3.3 Gross Profit, 2017-2021
13.12.3.4 R&D, 2018-2021
13.12.4 Product Benchmarking
13.12.5 Strategic Outlook
13.13 Canon Medical Systems Corporation
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 Regional Market Shares, 2021
13.13.3.3 Gross Profit, 2017-2021
13.13.3.4 R&D, 2017-2021
13.13.4 Product Benchmarking
13.13.5 Strategic Outlook
13.14 Johnson & Johnson Services, Inc.
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 Gross Profit, 2017-2021
13.14.3.3 R&D, 2017-2021
13.14.4 Product Benchmarking
13.14.5 Strategic Outlook
13.15 Siemens Healthcare GmbH
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2021
13.15.3.2 Regional Market Shares, 2021
13.15.3.3 R&D, 2017-2021
13.15.4 Product Benchmarking
13.15.5 Strategic Outlook
13.16 Edwards Lifesciences Corporation
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2017-2021
13.16.3.2 Gross Profit, 2017-2021
13.16.3.3 R&D, 2017-2021
13.16.4 Product Benchmarking
13.16.5 Strategic Outlook
13.17 LivaNova PLC
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2021
13.17.3.2 Gross Profit, 2017-2021
13.17.3.3 R&D, 2017-2021
13.17.4 Product Benchmarking
13.17.5 Strategic Outlook

14 Conclusion and Recommendations
14.1 Concluding Remarks from
14.2 Recommendations for Market Players



★調査レポート[世界の心血管装置市場2023年～2033年] (コード：VGA23FB012)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の心血管装置市場2023年～2033年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のニューロテックデバイス市場2023年～2033年
  • 世界の神経刺激装置市場2023年～2033年
  • 世界のバイオディフェンス市場2023年～2033年
  • 世界の治験用品市場2023年～2033年
  • 世界のPoC診断市場2023年～2033年
  • 世界の髄膜炎菌ワクチン市場2023年～2033年
  • 世界のアレルギー性鼻炎薬市場2023年～2033年
  • 世界の抗生物質市場2023年～2033年
  • 世界の喘息＆COPD治療市場2023年～2033年

    • ◆H&Iグローバルリサーチのお客様（例）◆